335 Results

People

  1. Pastores
    Pastores
  2. Brennan
    Brennan
  3. Sepkowitz
    Sepkowitz
  4. Horwitz
    Horwitz
  5. Dunkel
    Dunkel
  6. Heller
    Heller
  7. Herr
    Herr
  8. Kelsen
    Kelsen
  9. Zelenetz
    Zelenetz
  10. Abou-Alfa
    Abou-Alfa

Groups

  1. Department of Medicine (168)
  2. Hematologic Malignancies, Division of (78)
  3. Center for Hematologic Malignancies (74)
  4. Solid Tumor Oncology Division (74)
  5. Surgery (69)
  6. Survivorship Research (47)
  7. Anesthesiology and Critical Care Medicine (30)
  8. Adult Leukemia (28)
  9. Center for Pancreatic Cancer Research (28)
  10. Division of Subspecialty Medicine (27)
  1. "sepsis"
Formats
  1. Journal Article (305)
  2. Review (13)
  3. Editorial (5)
  4. Research Letter (4)
  5. Conference Paper (3)
  6. Correspondence (3)
  7. Guidelines (2)
Groups
  1. Department of Medicine (168)
  2. Hematologic Malignancies, Division of (78)
  3. Center for Hematologic Malignancies (74)
  4. Solid Tumor Oncology Division (74)
  5. Surgery (69)
  6. Survivorship Research (47)

More Groups

People
  1. Stephen Pastores (22)
  2. Murray Brennan (11)
  3. Kent Sepkowitz (9)
  4. Martin Tallman (9)
  5. Steven Horwitz (8)
  6. Andrew Zelenetz (7)

More People

Years
  1. 2025 (19)
  2. 2024 (26)
  3. 2023 (19)
  4. 2022 (12)
  5. 2021 (7)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Cancer (15)
  3. Lancet Oncology (13)
  4. Leukemia and Lymphoma (12)
  5. Blood (11)
  6. Journal of Urology (8)

More Publications

Publishers
  1. Elsevier Science, Inc. (36)
  2. Elsevier Inc. (33)
  3. American Society of Clinical Oncology (24)
  4. Wiley Blackwell (22)
  5. Lippincott Williams & Wilkins (19)
  6. Nature Publishing Group (18)

More Publishers

Results (335)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
    Journal Article

    Laurence, J.; Mulvey, J. J.; Seshadri, M.; Racanelli, A.; Harp, J.; Schenck, E. J.; Zappetti, D.; Horn, E. M.; Magro, C. M.
    Clinical Immunology (2020)

    Fulltext@MSK | Save
  • Racial disparities in clinical presentation, type of intervention, and in-hospital outcomes of patients with metastatic spine disease: An analysis of 145,809 admissions in the United States
    Journal Article

    De la Garza Ramos, R.; Benton, J. A.; Gelfand, Y.; Echt, M.; Flores Rodriguez, J. V.; Yanamadala, V.; Yassari, R.
    Cancer Epidemiology (2020)

    Fulltext@MSK | Save
  • Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: A randomized, open-label, multicenter, phase 2 study (CENTAURUS)
    Journal Article

    Landgren, C. O.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P.; Estell, J. A.; Sandhu, I.; Jenner, M. W.; Williams, C.; Cavo, M.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients
    Journal Article

    Blouin, A. G.; Hsu, M.; Fleisher, M.; Ramanathan, L. V.; Pastores, S. M.
    Clinica Chimica Acta (2020)

    Fulltext@MSK | Save
  • Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage
    Review

    Choi, K. J.; Nam, J. K.; Kim, J. H.; Choi, S. H.; Lee, Y. J.
    Experimental and Molecular Medicine (2020)

    Fulltext@MSK | Save
  • Treating sepsis with vitamin C, thiamine, and hydrocortisone: Exploring the quest for the magic elixir
    Review

    Obi, J.; Pastores, S. M.; Ramanathan, L. V.; Yang, J.; Halpern, N. A.
    Journal of Critical Care (2020)

    Fulltext@MSK | Save
  • Selinexor: A first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma
    Review

    Peterson, T. J.; Orozco, J.; Buege, M.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy
    Journal Article

    Hu, Q. L.; Liu, J. B.; Ellis, R. J.; Liu, J. Y.; Yang, A. D.; D'Angelica, M. I.; Ko, C. Y.; Merkow, R. P.
    HPB (2020)

    Fulltext@MSK | Save
  • Results of the NRG Oncology/RTOG 0848 adjuvant chemotherapy question - Erlotinib+gemcitabine for resected cancer of the pancreatic head: A phase II randomized clinical trial
    Journal Article

    Abrams, R. A.; Winter, K. A.; Safran, H.; Goodman, K. A.; Regine, W. F.; Berger, A. C.; Gillin, M. T.; Philip, P. A.; Lowy, A. M.; Wu, A.; more...
    American Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save